2026/0448- Agregação centralizada para adicionais de Medicamentos para o ano de 2026
Title in Portuguese as published on TED.
Contract award notice published on TED on 11 Nov 2026 by OUTRAS INSTITUIÇÕES DE SAÚDE (Portugal), CPV 33600000 Pharmaceutical products. Awarded to BIOJAM, S.A., Cencora 3PL Portugal, S.A., Celltrion Portugal, Unipessoal, Lda and 8 more for EUR 868,365.
| Notice | 785233-2026 (can-standard) |
|---|---|
| Status | Contract award |
| Published | 11 Nov 2026 |
| Buyer | OUTRAS INSTITUIÇÕES DE SAÚDE, TODAS |
| Country | Portugal |
| Main CPV | 33600000-6 Pharmaceutical products |
| Contract type | supplies |
| Procedure | open |
| Estimated value | EUR 954,204 excl. VAT |
| Awarded value | EUR 868,365 |
| Tenders received | 7 |
| Award decision | 21 Sep 2026 |
Daily EU tender alerts
Basic $19 a month, up to 5 filters. Pro $49 a month, up to 30 filters and tenders closing within 5 days. Charged in UAH at the National Bank of Ukraine rate on the payment day.
Description
2026/0448- Agregação centralizada para adicionais de Medicamentos para o ano de 2026
Lots (20)
| Lot | Title | Estimated value | Deadline |
|---|---|---|---|
| LOT-0001 | ACETILCISTEÍNA [600MG; COMP.EFERV] | EUR 282 | |
| LOT-0002 | ACIDO CARGLÚMICO [200 MG COMP. DISPERSÍVEL] | EUR 11,388 | |
| LOT-0003 | BEVACIZUMAB [25 MG/ML; 100 MG/ 4 ML; CONC P/A SOL P/A PERFUSÃO; FRS] + BEVACIZUMAB [25 MG/ML; 400 MG/ 16 ML; CONC P/A SOL P/A PERFUSÃO; FRS] | EUR 192,090 | |
| LOT-0004 | BEVACIZUMAB [25 MG/ML; 100 MG/ 4 ML; CONC P/A SOL P/A PERFUSÃO; FRS] + BEVACIZUMAB [25 MG/ML; 400 MG/ 16 ML; CONC P/A SOL P/A PERFUSÃO; FRS] | EUR 99,249 | |
| LOT-0005 | DENOSUMAB [120 MG; SOL INJ; FRS] | EUR 8,686 | |
| LOT-0006 | DENOSUMAB [60 MG; SOL INJ; FRS/SERINGA] | EUR 370 | |
| LOT-0007 | DAPAGLIFLOZINA [10 MG; CÁP/ COMP] | EUR 22,650 | |
| LOT-0008 | ECULIZUMAB [300 MG; SOL INJ; FRS] | EUR 222,729 | |
| LOT-0009 | ECULIZUMAB [300 MG; SOL INJ; FRS] | EUR 215,979 | |
| LOT-0010 | METAMIZOL MAGNÉSICO [575 MG; CÁP/COMP] | EUR 2,416 | |
| LOT-0011 | METAMIZOL MAGNÉSICO [575 MG; CÁP/COMP] | EUR 540 | |
| LOT-0012 | NILOTINIB [150 MG; CÁP/COMP] | EUR 2,094 | |
| LOT-0013 | NINTEDANIB [100MG; CÁPS] | EUR 37,930 | |
| LOT-0014 | NINTEDANIB [100MG; CÁPS] | EUR 8,232 | |
| LOT-0015 | NINTEDANIB [100MG; CÁPS] | EUR 7,474 | |
| LOT-0016 | NINTEDANIB [150MG; CÁPS] | EUR 54,029 | |
| LOT-0017 | OLANZAPINA [10 MG; COMP ORODISP] | EUR 428 | |
| LOT-0018 | PANTOPRAZOL [20MG; CÁP/COMP] | EUR 321 | |
| LOT-0019 | TETRABENAZINA [25MG; COMP] | EUR 36,650 | |
| LOT-0020 | TAMOXIFENO [20MG; COMP] | EUR 30,668 |
Winners
- BIOJAM, S.A.
- Cencora 3PL Portugal, S.A.
- Celltrion Portugal, Unipessoal, Lda
- Zentiva Portugal, Lda
- Samsung Bioepis NL B.V.
- Overpharma, Produtos Médicos e Farmacêuticos, Lda
- Generis Farmacêutica, S.A.
- Accord Healthcare Unipessoal Lda
- FARMOZ - Sociedade Técnico Medicinal, S.A.
- Profarin - Distribuidora Produtos Farmacêuticos Industriais, Lda
- Fresenius Kabi Pharma Portugal, Lda
More Pharmaceutical products in Portugal
Get new pharmaceutical products tenders by email
A free weekly digest of new competition notices from TED. One-click unsubscribe in every email.
Daily EU tender alerts
Basic $19 a month, up to 5 filters. Pro $49 a month, up to 30 filters and tenders closing within 5 days. Charged in UAH at the National Bank of Ukraine rate on the payment day.